Treatment Strategy for Rifampin-Susceptible Tuberculosis.

Paton, Nicholas I; Cousins, Christopher; Suresh, Celina; Burhan, Erlina; Chew, Ka Lip; Dalay, Victoria B; Lu, Qingshu; Kusmiati, Tutik; Balanag, Vincent M; Lee, Shu Ling; +12 more... Ruslami, Rovina; Pokharkar, Yogesh; Djaharuddin, Irawaty; Sugiri, Jani JR; Veto, Rholine S; Sekaggya-Wiltshire, Christine; Avihingsanon, Anchalee; Sarin, Rohit; Papineni, Padmasayee; Nunn, Andrew J; Crook, Angela M; TRUNCATE-TB Trial Team; (2023) Treatment Strategy for Rifampin-Susceptible Tuberculosis. The New England journal of medicine, 388 (10). pp. 873-887. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa2212537

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1056/NEJMoa2212537

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre TB Centre
PubMed ID 36808186
Elements ID 199557
Official URL http://dx.doi.org/10.1056/nejmoa2212537

Share

Download

Filename: Paton-etal-2023-Treatment-strategy-for-rifampin-susceptible.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar